Jeffrey Chodakewitz
Direttore/Membro del Consiglio presso SCHRÖDINGER, INC.
Patrimonio netto: 10 679 $ in data 30/04/2024
Posizioni attive di Jeffrey Chodakewitz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SCHRÖDINGER, INC. | Direttore/Membro del Consiglio | 30/04/2020 | - |
| Independent Dir/Board Member | 30/04/2020 | - | |
| ADICET BIO, INC. | Direttore/Membro del Consiglio | 15/09/2020 | - |
| Independent Dir/Board Member | 15/09/2020 | - | |
| PRAXIS PRECISION MEDICINES, INC. | Direttore/Membro del Consiglio | 13/04/2021 | - |
| Independent Dir/Board Member | 13/04/2021 | - | |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Corporate Officer/Principal | - | - |
The American Society for Clinical Pharmacology & Therapeutics
 The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Corporate Officer/Principal | - | - |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jeffrey Chodakewitz
Precedenti posizioni note di Jeffrey Chodakewitz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FREELINE THERAPEUTICS HOLDINGS PLC | Direttore/Membro del Consiglio | 26/06/2020 | 20/02/2024 |
| Independent Dir/Board Member | 06/08/2020 | 20/02/2024 | |
| TETRAPHASE PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 17/06/2014 | 28/07/2020 |
| Independent Dir/Board Member | 17/06/2014 | 28/07/2020 | |
| VERTEX PHARMACEUTICALS INCORPORATED | Direttore Tecnico/Scientifico/R&S | 08/01/2014 | 01/04/2018 |
| Corporate Officer/Principal | 01/04/2018 | 02/04/2018 | |
| ░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Jeffrey Chodakewitz
| Yale University | Undergraduate Degree |
| Yale School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 14 |
| Regno Unito | 3 |
Posizioni
| Director/Board Member | 8 |
| Independent Dir/Board Member | 6 |
| Corporate Officer/Principal | 5 |
Settori
| Health Technology | 10 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| MERCK & CO., INC. | Health Technology |
| SCHRÖDINGER, INC. | Technology Services |
| ADICET BIO, INC. | Health Technology |
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
The American Society for Clinical Pharmacology & Therapeutics
The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Commercial Services |
Veterans Administration Medical Center
 Veterans Administration Medical Center Hospital/Nursing ManagementHealth Services Veterans Administration Medical Center provides healthcare services. The private company is based in San Diego, CA. | Health Services |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey Chodakewitz
- Esperienza